<DOC>
	<DOCNO>NCT00830310</DOCNO>
	<brief_summary>This study modular intervention intend improve treatment adherence among individual bipolar disorder atypical antipsychotic therapy identify treatment adherence problem .</brief_summary>
	<brief_title>Customized Medication Adherence Enhancement Adults With Bipolar Disorder</brief_title>
	<detailed_description>This study pilot , prospective project effect customize adherence enhancement ( CAE ) add medical management ( usual care ) outpatients bipolar disorder ( BPD ) patient University Hospitals Cleveland Case Medical Center , know risk treatment non-adherence . In proposed trial , CAE support manual deliver series four module whose use determine base upon individual 's identify treatment adherence vulnerability . The module component single , customized intervention . Although participant may receive different combination number module , participant neither analyze separately subpopulation compare subpopulation . Therefore participant part solitary study arm . The effectiveness entire customize intervention system interest . All individual continue receive treatment usual regular provider . Those enrolled study intervention participate series 4 in-person meeting study interventionist 4-week time period 1-2 telephone follow-up . These meeting interventionist consist whatever module assign baseline customize particular participant 's treatment adherence vulnerability . A total 3 4 assessment meeting research assistant occur three-month time period . Primary objective The aim project test use modular-based intervention pilot feasibility , acceptability preliminary efficacy study customize adherence enhancement ( CAE ) vulnerable population BPD . We hypothesize CAE : 1 ) feasible administer within academic medical center ; 2 ) acceptable participant BPD ; 3 ) associate improvement treatment adherence . Secondary objective Individuals receive CAE improvement BPD symptom , global psychopathology , overall treatment attitude functional status .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Clinical diagnosis Bipolar Disorder ( BPD ) Type I Type II determine standardize diagnostic interview , MiniInternational Neuropsychiatric Interview ( MINI ) ( Sheehan 1998 ) ; Demonstrated history poor adherence per either selfreport clinician report . In study , selfreported treatment nonadherence identify Tablet Routines Questionnaire ( TRQ ) . Poorly adherent individual define miss 20 % medication within either past week past month ( miss 20 % within past week consider nonadherent past month ) . BPD least two year duration ; Treatment atypical antipsychotic medication stabilize mood least six month ; The ability participate psychiatric interview give write , inform consent study participation ; Age 18 older . Unable/unwilling participate psychiatric interview base clinical opinion investigator treat clinician . Individuals grossly psychotic may exclude point treat clinician feel prospective participant unable participate interview study procedure ; Unable/unwilling give write , inform consent study participation ; High risk suicide ( e.g. , active suicidal ideation recent suicide attempt ; active suicidal ideation current intent plan ) . In interest patient safety , individual acutely suicidal exclude study participation ; Individuals nonEnglish speaking exclude study assessment tool available language would impractical develop small , exploratory study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Patient Non-Adherence</keyword>
	<keyword>Patient Non-Compliance</keyword>
	<keyword>Patient Nonadherence</keyword>
	<keyword>Patient Noncompliance</keyword>
	<keyword>Patient Refusal Treatment</keyword>
	<keyword>Refusal Treatment</keyword>
	<keyword>Treatment Refusal</keyword>
</DOC>